ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,737,835 | +344.5% | 107,156 | +157.8% | 0.02% | +320.0% |
| Q3 2022 | $616,000 | -92.1% | 41,567 | -91.7% | 0.01% | -93.4% |
| Q2 2022 | $7,840,000 | +282.1% | 498,097 | +554.6% | 0.08% | +322.2% |
| Q1 2022 | $2,052,000 | -83.2% | 76,096 | -77.0% | 0.02% | -83.8% |
| Q4 2021 | $12,241,000 | +70.1% | 330,748 | +119.6% | 0.11% | +48.0% |
| Q3 2021 | $7,197,000 | +804.1% | 150,627 | +540.1% | 0.08% | +837.5% |
| Q2 2021 | $796,000 | +0.4% | 23,532 | +22.5% | 0.01% | -20.0% |
| Q1 2021 | $793,000 | -48.2% | 19,208 | -45.5% | 0.01% | -52.4% |
| Q4 2020 | $1,530,000 | -83.4% | 35,268 | -83.5% | 0.02% | -88.0% |
| Q3 2020 | $9,196,000 | +406.4% | 214,370 | +451.4% | 0.18% | +629.2% |
| Q2 2020 | $1,816,000 | – | 38,874 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |